Covaxin booster dose shows neutralising effect on Omicron, Delta variants, states Study Ruchika Sharma13 Jan 2022 1:08 PM ISTNew Delhi: Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta...
USFDA warns against rare bleeding risk of JnJ COVID vaccine Ruchika Sharma12 Jan 2022 4:15 PM ISTNew Delhi: The U.S. Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson's COVID-19 vaccine to include a rare...
JnJ Single shot vaccine protects against breakthrough COVID-19 for up to 6 months: Study Roshni Dhar12 Jan 2022 11:47 AM ISTJohnson & Johnson said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and...
Moderna eyes USD 22 billion from COVID vaccine, booster sales in 2022 Ruchika Sharma12 Jan 2022 9:00 AM ISTNew Delhi: Moderna Inc said on Monday it expected to record sales of about $18.5 billion in 2022 from contracts for its COVID-19 vaccine, and...
Covaxin booster dose safe, says Bharat Biotech Ruchika Sharma11 Jan 2022 3:44 PM ISTNew Delhi: Covaxin manufacturer Bharat Biotech on Saturday said that the booster dose trials have shown "promising results" of long-term safety...
Boosters increase vaccine efficacy against Omicron by 88 percent, claims study MD Bureau3 Jan 2022 10:30 AM ISTLondon: Although the Omicron variant of Covid has been shown to evade vaccines, two new studies led by the UK health agency showed that a third...
More Covaxin doses supplied to Afghanistan: Bharat Biotech Ruchika Sharma3 Jan 2022 10:00 AM ISTNew Delhi: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19...
Pfizer-BioNTech COVID vaccine causes mostly mild side effects in children aged 5 to 11 years, says USCDC Ruchika Sharma2 Jan 2022 10:00 AM ISTNew Delhi: Pfizer Inc and BioNTech SE's COVID-19 vaccine caused mostly mild side effects in children aged 5 to 11 years, according to data...
Serum Institute files for full CDSCO approval of Covishield Ruchika Sharma1 Jan 2022 1:01 PM ISTNew Delhi: Serum Institute of India (SII) CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market...
Novavax files data with USFDA to back COVID vaccine Ruchika Sharma1 Jan 2022 10:00 AM ISTGaithersburg: Novavax, Inc. has announced that the company has completed submission of the final data package, including the complete chemistry,...
Study shows Covaxin safe, immunogenic in 2-18 age group: Bharat Biotech Ruchika Sharma31 Dec 2021 12:48 PM ISTHyderabad: Bharat Biotech International Limited (BBIL), has announced that BBV152 (COVAXIN), its whole-virion inactivated COVID-19 vaccine candidate,...
Biological E in talks with WHO over Corbevax approval, says Developer Ruchika Sharma31 Dec 2021 12:00 PM ISTHouston: Corbevax, a 'recombinant protein sub-unit' vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by...
